Compile Data Set for Download or QSAR
maximum 50k data
Found 183 Enz. Inhib. hit(s) with all data for entry = 557
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3847(1-Phenylbenzimidazole deriv. 64 | 5-Substituted 1-...)
Affinity DataIC50:  430nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3848(1-Phenylbenzimidazole deriv. 65 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  440nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3878(1-Phenylbenzimidazole deriv. 95 | 5-methoxy-1-(thi...)
Affinity DataIC50:  700nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3851(1-Phenylbenzimidazole deriv. 68 | methyl 1-phenyl-...)
Affinity DataIC50:  830nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3855(1-(1-phenyl-1H-1,3-benzodiazol-5-yl)ethan-1-one | ...)
Affinity DataIC50:  860nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3823(1-Phenylbenzimidazole deriv. 40 | 4-(1H-1,3-benzod...)
Affinity DataIC50:  1.80E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3860(1-Phenylbenzimidazole deriv. 77 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  2.10E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3877(1-Phenylbenzimidazole deriv. 94 | 5-methoxy-1-(thi...)
Affinity DataIC50:  2.50E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3854(1-Phenylbenzimidazole deriv. 71 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  2.70E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3816(1-Phenylbenzimidazole deriv. 33 | 3-(1H-1,3-benzod...)
Affinity DataIC50:  3.60E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3810(1-Phenylbenzimidazole deriv. 27 | 3-(1H-1,3-benzod...)
Affinity DataIC50:  3.80E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3849(1-Phenylbenzimidazole deriv. 66 | 5-chloro-1-pheny...)
Affinity DataIC50:  4.00E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3846(1-Phenylbenzimidazole deriv. 63 | 5-methyl-1-pheny...)
Affinity DataIC50:  4.40E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3877(1-Phenylbenzimidazole deriv. 94 | 5-methoxy-1-(thi...)
Affinity DataIC50:  5.30E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3861(1-Phenylbenzimidazole deriv. 78 | 6-chloro-1-pheny...)
Affinity DataIC50:  5.40E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3829(1-Phenylbenzimidazole deriv. 46 | 4-(1H-1,3-benzod...)
Affinity DataIC50:  5.60E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3823(1-Phenylbenzimidazole deriv. 40 | 4-(1H-1,3-benzod...)
Affinity DataIC50:  5.80E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3848(1-Phenylbenzimidazole deriv. 65 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  6.40E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3859(1-Phenylbenzimidazole deriv. 76 | 6-methoxy-1-phen...)
Affinity DataIC50:  6.40E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3878(1-Phenylbenzimidazole deriv. 95 | 5-methoxy-1-(thi...)
Affinity DataIC50:  6.50E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3851(1-Phenylbenzimidazole deriv. 68 | methyl 1-phenyl-...)
Affinity DataIC50:  6.60E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3818(1-(3-Formylphenyl)benzimidazole | 1-Phenylbenzimid...)
Affinity DataIC50:  6.80E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3826(1-Phenylbenzimidazole deriv. 43 | methyl 4-(1H-1,3...)
Affinity DataIC50:  7.20E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3856(1-Phenylbenzimidazole deriv. 73 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  8.40E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3794(1-Phenylbenzimidazole 3 | 1-Phenylbenzimidazole de...)
Affinity DataIC50:  9.30E+3nMpH: 7.4 T: 2°CAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3850(1-Phenylbenzimidazole deriv. 67 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  9.30E+3nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3852(1-Phenylbenzimidazole deriv. 69 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  1.00E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3857(1-Phenylbenzimidazole deriv. 74 | 1-Phenylimidazo-...)
Affinity DataIC50:  1.00E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3839(1-Phenylbenzimidazole 4 | 1-Phenylbenzimidazole de...)
Affinity DataIC50:  1.10E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3833(1-(pyridin-4-yl)-1H-1,3-benzodiazole | 1-Phenylben...)
Affinity DataIC50:  1.20E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3863(1-Phenylbenzimidazole deriv. 80 | methyl 1-phenyl-...)
Affinity DataIC50:  1.30E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3831(1-Phenylbenzimidazole deriv. 48 | 4-(1H-1,3-benzod...)
Affinity DataIC50:  1.30E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3822(1-(4-methoxyphenyl)-1H-1,3-benzodiazole | 1-Phenyl...)
Affinity DataIC50:  1.30E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3855(1-(1-phenyl-1H-1,3-benzodiazol-5-yl)ethan-1-one | ...)
Affinity DataIC50:  1.40E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3853(1-Phenylbenzimidazole deriv. 70 | 5-nitro-1-phenyl...)
Affinity DataIC50:  1.60E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3832(1-Phenylbenzimidazole deriv. 49 | 4-(1H-1,3-benzod...)
Affinity DataIC50:  1.60E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3815(1-(3-nitrophenyl)-1H-1,3-benzodiazole | 1-Phenylbe...)
Affinity DataIC50:  1.60E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3852(1-Phenylbenzimidazole deriv. 69 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  1.60E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3817(1-Phenylbenzimidazole deriv. 34 | 1-[3-(1H-1,3-ben...)
Affinity DataIC50:  1.90E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3847(1-Phenylbenzimidazole deriv. 64 | 5-Substituted 1-...)
Affinity DataIC50:  2.20E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3866(1-Phenylbenzimidazole deriv. 83 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  2.30E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3827(1-(4-Carboxamidophenyl)benzimidazole | 1-Phenylben...)
Affinity DataIC50:  2.30E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3830(1-Phenylbenzimidazole deriv. 47 | 1-[4-(1H-1,3-ben...)
Affinity DataIC50:  2.40E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3864(1-Phenylbenzimidazole deriv. 81 | 1-phenyl-1H-1,3-...)
Affinity DataIC50:  2.50E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3809(1-(3-methoxyphenyl)-1H-1,3-benzodiazole | 1-Phenyl...)
Affinity DataIC50:  2.50E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3876(1-Phenyl-1H-imidazo[5,4-b]pyridine Dihydrochloride...)
Affinity DataIC50:  2.80E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3849(1-Phenylbenzimidazole deriv. 66 | 5-chloro-1-pheny...)
Affinity DataIC50:  2.80E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3808(1-(3-methylphenyl)-1H-1,3-benzodiazole | 1-Phenylb...)
Affinity DataIC50:  2.80E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3828(1-(4-nitrophenyl)-1H-1,3-benzodiazole | 1-Phenylbe...)
Affinity DataIC50:  3.00E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
University Of Auckland

LigandPNGBDBM3815(1-(3-nitrophenyl)-1H-1,3-benzodiazole | 1-Phenylbe...)
Affinity DataIC50:  3.50E+4nMAssay Description:IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 183 total ) | Next | Last >>
Jump to: